Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitatene was a Spanish biotechnology company specializing in the production of natural carotenoids through advanced microbial fermentation processes. Based in León, the company utilized the fungus Blakeslea trispora to manufacture high-quality beta-carotene and lycopene for the food, beverage, and dietary supplement industries. Vitatene was notable for being the first company to receive Novel Food approval in the European Union for beta-carotene derived from this specific fermentation method. In 2010, the company was acquired by DSM (now dsm-firmenich) to bolster its portfolio of natural nutritional ingredients. Today, its technology and facilities continue to contribute to the global supply of sustainable, natural antioxidants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitatene.